Skip to main content

Month: June 2022

Suominen launches a nonwoven made with recycled paper

Suominen Corporation’s press release on June 2, 2022 at 1:00 p.m. (EEST) Suominen further strengthens its position as the frontrunner in sustainable nonwovens by launching HYDRASPUN® Circula, the market’s first ever nonwoven made with recycled paper. HYDRASPUN® Circula is biodegradable, plastic-free and can be used in multiple applications. The product was created in cooperation with Codi Group, one of Europe’s leading wet wipe producers. Drawing from both parties’ industry expertise, the new product offers a variety of applications to meet consumers’ daily needs. “It is important for Suominen to continuously develop new sustainable products to be able to offer even more choices to our customers. HYDRASPUN® Circula is a perfect example of how we can develop our nonwovens with innovations and more sustainable raw materials. HYDRASPUN® Circula...

Continue reading

Reviva Pharmaceuticals to Participate in the 2022 BIO International Convention

CUPERTINO, Calif.,, June 02, 2022 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a clinical-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), cardiovascular, metabolic, and inflammatory diseases, today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in the 2022 BIO International Convention, to be held June 13-16 in San Diego, CA. Please see additional details below: 2022 BIO International Convention – (Hybrid) Date: Tuesday, June 14, 2022Time: 12:15 p.m. (PT)/ 3:15 p.m. (ET)Location: San Diego, CAFormat: Company Presentation & One-On-One MeetingsRegistration: Click Here The Reviva team invites registered attendees to participate via...

Continue reading

Genetron Health Releases 10 New Research Results at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

BEIJING, June 02, 2022 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced the release of 10 research results at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Based on Genetron Health’s patented One-Step™ Seq Method and core products such as Onco PanScan™, the results aimed to contribute to the scientific research and clinical practice of full-cycle cancer management. These studies involved an in-depth analysis of the Chinese population and focused on analyzing the characteristics of gene mutations and fusion mapping of multiple cancer types, including lung cancer and...

Continue reading

Canadian Credit Market Surges as Economy Recovers

Chart 1: Canadian Credit Industry Indicator A lower CII number compared to the prior period represents a decline in credit health, while a higher number reflects an improvement. The CII number needs to be looked at in relation to the previous period(s) and not in isolation. In March 2022, the CII of 105.3 represented an improvement in credit health compared to the same month prior year (March 2021) and a slight decline in credit health compared to the prior month (February 2021).In Q1 2022, TransUnion’s Credit Industry Indicator increased 22 points year-on-year, returning to pre-pandemic levels, as all underlying factors improved over the period Under strengthening economic fundamentals, credit participation grew and originations and balances increased as consumers and lenders became more active Rising inflation and interest rates...

Continue reading

GDS to Hold Annual General Meeting on June 30, 2022

SHANGHAI, China, June 02, 2022 (GLOBE NEWSWIRE) — GDS Holdings Limited (“GDS Holdings,” “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data centers in China, today announced that it will hold its 2022 Annual General Meeting of Shareholders (the “AGM”) at Beijing Meeting Room, F5, Building C, Sunland International, No. 999 Zhouhai Road, Pudong, Shanghai, P.R.C. at 4:00 p.m. (China Standard Time) on June 30, 2022 (which is 4:00 a.m. (Eastern Daylight Time) on June 30, 2022). Holders of the Company’s ordinary shares and Series A convertible preferred shares listed in the register of members of the Company at the close of business on June 1, 2022 (China Standard Time) are entitled to receive notice of, and vote at, the AGM or at any adjournment that may take place. Beneficial...

Continue reading

Centessa Pharmaceuticals Makes Strategic Decision to Discontinue Clinical Development of Lixivaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

– Decision based on reassessment of commercial potential of lixivaptan following recent observation of ALT/AST elevations in ALERT Study – – Discontinuation of lixivaptan development expected to significantly reduce cash burn and extend cash runway into 2026 – – Company continues to focus on the development of its innovative high impact rare disease and immuno-oncology pipeline of investigational medicines for patients – BOSTON and LONDON, June 02, 2022 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA), today announced that it has made the strategic decision to discontinue development of lixivaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) including both the Phase 3 ACTION Study and the open-label ALERT Study. The decision is based on a thorough reassessment of the...

Continue reading

TRX Gold Confirms Northeast Extension of the Buckreef Gold Main Zone and Expands Exploration Program With Additional Drill Rig

Drill Results Include 28.0 m @ 3.27 g/t, Including 7.0m @ 7.27 g/tTable 1.1 Buckreef Main Zone Northeast Extension (NEE) Assay Results. *Figure 1 Map Showing Mineralization Extension and Location of Drill Results at Buckreef Main Zone Northeast Extension (Drone Base Image Date – May 2021. Oxide Pit outline as of April 2022).Figure 2 Section 30 – Looking to North-East.Figure 3 Section 28 – Looking to North-East.Figure 4 Buckreef Gold Drill Rig in Northeast Extension.Figure 5 Buckreef Gold Open Pit (May 2022) with view towards North-East and Drill Rig Location.TORONTO, June 02, 2022 (GLOBE NEWSWIRE) — TRX Gold Corporation (TSX:TNX) (NYSE American:TRX) (the “Company” or “TRX Gold”) is pleased to announce a 250 meter (m) extension of the Buckreef Gold Main Zone to 1.8 Kilometers (kms) and positive assay...

Continue reading

Credit Card Spending Ramps Up as Inflation Soars

Equifax Canada Market Pulse Quarterly Credit Trends Report TORONTO, June 02, 2022 (GLOBE NEWSWIRE) — Consumer reliance on credit cards is increasing, with the average monthly spend per credit card consumer climbing by 17.5 per cent in Q1 2022 compared to the lows of Q1 2021, according to Equifax Canada’s most recent Market Pulse consumer credit trends and insights report. Ontario saw the biggest increase in credit card spending (up by 20.4 per cent) followed by Quebec (18.4 per cent) when compared to the same time period last year. “Pent-up demand and increased travel with the easing of COVID restrictions, combined with soaring inflation have led to some of the highest increases in credit card spending we’ve ever seen. Unfortunately for consumers, this is also at a time when the Bank of Canada is raising interest rates,” said Rebecca...

Continue reading

Huize Launches its First Customized Educational Annuity Insurance with Heng An Standard Life

SHENZHEN, China, June 02, 2022 (GLOBE NEWSWIRE) — Huize Holding Limited, (“Huize”, the “Company” or “we”) (NASDAQ: HUIZ), a leading digital insurance product and service platform for new generation consumers in China, today announced that it has partnered with Heng An Standard Life Insurance Company Limited (“HASL”, a joint venture of Tianjin TEDA International Holdings (Group) Company Limited and Aberdeen Group in the UK) to launch “Jin Zhi Qi Hang”, a customized annuity product dedicated to meet clients’ savings needs for their children’s future education. There are three key product highlights of “Jin Zhi Qi Hang”: (i) the insurance benefits can be used to cover children’s higher education expenses from undergraduate to postgraduate degrees (the beneficiary will receive 10% of the total premium paid per annum between the ages...

Continue reading

ALSTOM SA: 2021 Dividend Proposal at the Shareholders’ Meeting of 12 July 2022 – Distribution Schedule

2021 DIVIDEND PROPOSAL AT THE SHAREHOLDERS’ MEETING OF 12 JULY 2022 DISTRIBUTION SCHEDULE ALSTOMJoint Stock Company with a capital of €2,616,486,292Registered office: 48, rue Albert Dhalenne, 93400 Saint-Ouen-sur-SeineTrade and Company Register number 389 058 447 Bobigny 2 June 2022 – As already announced at the publication of the 2021 annual results on 11 May 2022, the Board of Directors has decided to propose to the Shareholders’ Meeting of 12 July 2022 the distribution of a dividend amounting to 0.25 euros gross per share, with an option for the payment of the dividend in cash or in new shares. As a reminder, this rate corresponds to a distribution ratio of 35% of the adjusted net income before depreciation of the stake in TMH. Subject to the approval of the Shareholders’ Meeting, the price of the share delivered in payment of...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.